• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by PepGen Inc.

< Previous 1 2 Next >
News headline image
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 06, 2026
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
August 06, 2026
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program
May 21, 2026
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 12, 2026
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
March 30, 2026
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
March 04, 2026
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Regulatory Updates on FREEDOM2
March 04, 2026
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Participate in the Leerink Global Healthcare Conference
March 03, 2026
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
December 09, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
December 08, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule
November 12, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 12, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Participate in Upcoming Investor Conferences
November 03, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society
October 02, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
September 26, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Pricing of $100 Million Public Offering
September 24, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Proposed Public Offering
September 24, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients
September 24, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
August 07, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update
May 28, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer
May 20, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 08, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference
April 02, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Appointment of Two New Directors to its Board
March 31, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
March 10, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen to Participate in Upcoming Investor Conferences
March 04, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
March 04, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
February 24, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
February 24, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
News headline image
PepGen Announces CONNECT Program Updates
January 29, 2025
From PepGen Inc.
Via Business Wire
Tickers PEPG
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap